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T-box genes are frequently expressed in dynamic patterns during animal development, but the
mechanisms controlling expression of these genes are not well understood. The Caenorhabditis elegans
T-box gene tbx-2 is essential for development of the ABa-derived pharyngeal muscles, speciﬁcation of
neural cell fate in the HSN/PHB lineage, and adaptation in olfactory neurons. The tbx-2 expression pattern
is complex, and expression has been described in pharyngeal precursors and body wall muscles during
embryogenesis, and amphid sensory neurons and pharyngeal neurons in adults. To examine mechanisms
regulating tbx-2 gene expression, we performed an RNAi screen of transcription factor genes in strains
containing a Ptbx-2::gfp reporter and identiﬁed the Nuclear Factor Y (NF-Y) complex as a negative
regulator of tbx-2 expression. NF-Y is a heterotrimeric CCAAT-binding complex consisting of A–C
subunits, and reduction of the NF-Y subunits nfya-1, nfyb-1, or nfyc-1 by RNAi or using mutants results
in ectopic Ptbx-2::gfp expression in hypodermal seam cells and gut. Mutation of two CCAAT-boxes in the
tbx-2 promoter results in a similar pattern of ectopic Ptbx-2::gfp expression, suggesting NF-Y directly
represses the tbx-2 promoter. tbx-2 mRNA is moderately increased in nfya-1 null mutants, indicating
NF-Y represses expression of endogenous tbx-2. Finally we identify and characterize a second-site
mutation that enhances lethality of a temperature sensitive tbx-2 mutant and show that this mutation is
a deletion in the nfyb-1 gene. Together, these results identify NF-Y as an important regulator of tbx-2
function in vivo.
& 2013 Elsevier Inc. All rights reserved.Introduction
T-box transcription factors play essential roles in the develop-
ment of all multicellular animals, where their functions include
the speciﬁcation of primary germ layers and the speciﬁcation of
cell fates during organogenesis [reviewed in (Naiche et al., 2005;
Showell et al., 2004)]. In humans, mutations in T-box genes have
recently been implicated in a variety of congenital diseases
and cancers, and, in most cases, the level of T-box gene expression
is a crucial determinant of disease. For example, haploinsufﬁciency
for the T-box genes TBX5, TBX3, TBX1, TBX22, and TBX19 results
in Holt–Oram syndrome, Ulnar–Mammary syndrome, DiGeorge
syndrome, cleft palate with ankyloglossia, and ACTH deﬁciency,
respectively [reviewed in (Packham and Brook, 2003)]. Conversely,
overexpression of TBX2 and TBX3 is observed in a variety
of cancers, including cancers of the breast, pancreas, ovary,
and skin [reviewed in (Abrahams et al., 2010; Lu et al., 2010)].
Because precise regulation of T-box gene expression is crucial forll rights reserved.
ciences, Harold Washingtonnormal function, several recent studies have focused on identifying
upstream regulators of mammalian T-box genes. These have
identiﬁed Wnt/ß-catenin and BMP/Smad signaling pathways, the
cell cycle regulators PML and E2F4, and the Nuclear Factor Y (NF-Y)
complex as regulators of T-box gene expression (Martin et al.,
2012; Renard et al., 2007; Smith et al., 2011; Teng et al., 2008;
Zhang et al., 2011).
We are characterizing mechanisms controlling T-box factor
expression and activity in Caenorhabditis elegans and are focusing
on the tbx-2 gene. TBX-2 is the sole C. elegansmember of the Tbx2-
subfamily of T-box factors, and it is most closely related to the
human proteins TBX2 and TBX3 (Pocock et al., 2004; Roy
Chowdhuri et al., 2006). During embryogenesis tbx-2 is required
for formation of pharyngeal muscles derived from the ABa
blastomere and for specifying the fate and differentiation pattern
of the HSN and PHB neurons, and null mutants exhibit larval
lethality resulting from an inability to feed (Roy Chowdhuri et al.,
2006; Singhvi et al., 2008; Smith and Mango, 2007). tbx-2 also
plays a role in neuronal plasticity, and viable non-null alleles have
defects in adaptation to odorants and formation of dauer larvae
(Miyahara et al., 2004). tbx-2 null mutants arrest as L1 larvae
shortly after hatching due to pharyngeal defects and an inability to
feed (Roy Chowdhuri et al., 2006; Smith and Mango, 2007).
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tbx-2 is expressed in a variety of tissues. tbx-2 expression has
been examined at different developmental stages using gfp repor-
ters (Roy Chowdhuri et al., 2006; Smith and Mango, 2007),
antibodies (Miyahara et al., 2004), and by in situ hybridization
[NEXTDB Ver. 4.0, yk112c4, http://nematode.lab.nig.ac.jp/db/index.
html; (Kohara, 2001)]. These analyses indicate tbx-2 is expressed
in a dynamic pattern, with strong expression in the developing
pharynx during embryogenesis and expression in a subset of
neurons from late embryogenesis through adulthood. tbx-2
expression outside the pharynx is repressed by LAG-1 and REF-1
components of the Notch signaling pathway, while expression in
the pharynx is maintained by PHA-4/FoxA in a positive feedback
loop (Smith and Mango, 2007).
To identify additional mechanisms controlling tbx-2 expression,
we performed an RNAi screen of transcription factor genes in
which we looked for altered expression of a tbx-2::gfp reporter.
We found that RNAi knockdown of the nfyc-1 subunit of the
CCAAT-box binding factor NF-Y resulted in ectopic tbx-2::gfp
expression in the seam cells and gut. nfyc-1 encodes one subunit
of the heterotrimeric NF-Y transcription factor. We used a variety
of genetic and molecular approaches that indicate the NF-Y
complex containing the NFYA-1, NFYB-1 and NFYC-1 subunits
directly targets the tbx-2 promoter and represses tbx-2 expression.
Further, we found strong genetic interactions between a newly
identiﬁed nfyb-1 mutant and a temperature sensitive tbx-2
mutant. Together, these results indicate NF-Y repression is crucial
for tbx-2 function in vivo.Materials and methods
Nematode handling, transformation, and strains
C. elegans were grown under standard conditions (Lewis and
Fleming, 1995). Germ line transformation was performed by
microinjection with pRF4 containing rol-6(su1006) as a transfor-
mation marker (100 ng/ml) with gfp reporters (10 ng/ml) (Mello and
Fire, 1995). The following strains were used in these studies:
OK0592 cuIs23[Ptbx-2::gfp] III, OK0969 rrf-3(pk1426) II; cuIs23 III
(Simmer et al., 2002), OK0029 cuIs1[ceh-22::gfp] (Okkema et al.,
1997), OK0041 cuIs3[8xB207::Δpes-10::gfp] (Okkema and Fire,
1994), VC763 nfya-1(ok1174) X (provided by International
C. elegans Gene Knockout Consortium), OK0971 cuIs23; nfya-1
(ok1174) X, OK0660 tbx-2(bx59) (Huber et al., 2013), OK0661
nfyb-1(cu13) II; tbx-2(bx59) III, OK0814 nfyb-1(cu13) II, OK0854
cuEx683[Ptbx-2prox::gfp], OK0855 cuEx684[Ptbx-2prox::gfp], OK0851
cuEx680[Ptbx-2dist::gfp], and OK0843 cuEx672[Ptbx-2prox+dist::gfp].
The chromosomally integrated Ptbx-2::gfp reporter OK0592
[cuIs23 III] bearing pOK206.33+pRF4 was derived from OK0551
cuEx482 following EMS mutagenesis and was outcrossed twice to
N2 (Anderson, 1995; Roy Chowdhuri et al., 2006). The tbx-2
promoter fragment in pOK206.33 contains 3787 bp upstream of
the tbx-2 ATG (bp 5139,963–5136,174 of LGIII, accession
NC_003281.10) inserted in-frame into the gfp plasmid pOK95.69
(provided by A. Fire, Stanford University). For crossing cuIs23 into
mutant backgrounds, multiplexed, single-worm PCR was used to
genotype animals for rrf-3(pk1426) using primers PO848
[TTCTGCGATTGCGATTGG], PO849 [GGTATTTATTGCTTCCTGCCAC],
and PO850 [GTCGTCTCTCTCCATTCCAGC]; nfya-1(ok1174) using
primers PO962 [AAAATGAATGGAGCGTCGAG]. PO963 [TGGACGT
GGTCGTGATATTG], and PO964 [TACTTTCCAGCAGCCGAATC], and
nfyb-1(cu13) using primers PO1381 [CAATTTTTGAGCTGGAAGCC],
PO1382 [TTACTGCAGGTAAAACCGGG], and PO1199 [CAGAAGCC-
GAAATTAAAAGCC] under conditions similar to those previously
described (Beaster-Jones and Okkema, 2004). tbx-2(bx59) disruptsa BstCI restriction site, and animals were genotyped for this allele
as described previously (Huber et al., 2013).
General methods for nucleic acid manipulations and plasmid
construction
Standard methods were used to manipulate plasmid DNAs and
oligonucleotides (Ausubel, 1990), and all plasmid sequences are
available from the authors. CCAAT-boxes at 3609 and 245 (bp
5139738–5139743 and 5136375–5136379, respectively, in LGIII,
accession NC_003281.10) using the Stratagene QuikChange II Kit
in the Ptbx-2::gfp plasmid pOK206.33 (Roy Chowdhuri et al., 2006)
to produce Ptbx-2prox::gfp plasmid pOK255.07 and Ptbx-2dist::gfp
plasmid pOK255.08, respectively, and the double mutant
Ptbx-2prox+dist::gfp plasmid pOK270.06 was constructed from these
plasmids using standard ligation. All plasmids were sequenced to
verify the presence of the mutations.
RNAi analyses
The RNAi feeding screen was modiﬁed from Kamath and
Ahringer (2003). E. coli strains for feeding RNAi of transcription
factor genes were recovered from the C. elegans RNAi feeding
library and the Transcription Factor sub-set (MRC Geneservice)
(Kamath and Ahringer, 2003; Reece-Hoyes et al., 2005), and
feeding RNAi was performed on OK0592 cuIs23[Ptbx-2::gfp] III or
in the RNAi hypersensitive strain OK0969 rrf-3(pk1426) II; cuIs23 III
at 20 1C or 16 1C, respectively. Brieﬂy, L4 hermaphrodites were
plated seeded RNAi plates for 24 h transferred to freshly seeded
RNAi plates, and removed after 1–3 days. The F1 progeny were
scored for lethality and morphological abnormalities, and for
alterations in Ptbx-2::gfp expression using a Leica MZ FLIII ﬂuor-
escence dissecting microscope and a Zeiss Axioskop compound
microscope.
RNAi analyses using injection of double-stranded RNA were
performed essentially as previously described (Fire et al., 1998).
dsRNA produced by vitro transcription (Ambion) of cDNAs from
nfya-1 (yk468e11/pOK296.01), nfya-2 (yk635h6/pOK296.03),
nfyb-1 (yk401d5/pOK296.05), nfyc-1 (yk232h5/pOK296.07), and
tbx-2 (yk112c4/pOK165.07) provided by Y. Kohara (National Insti-
tute of Genetics, Japan) was injected into Ptbx-2::gfp containing
strains at approximately 200–500 ng/ml at 20 1C. Injected animals
were transferred to fresh plates every 12 h, and animals laid 24–
48 h post injection were scored for altered Ptbx-2::gfp expression.
Quantiﬁcation of mRNA levels using real-time PCR
Synchronized N2 and nfya-1(ok1174) L1 larvae were prepared
by bleaching mixed-stage animals and allowing the isolated
embryos to grow 12 h on OP50 seeded NGM plates at 20 1C
(Lewis and Fleming, 1995). Total RNA was isolated using TRIzol
(Invitrogen), and puriﬁed using the RNeasy Mini Kit (Qiagen) and
the TURBO DNA-free kit (Ambion) according to manufacturers’
instructions. Reverse transcription and real-time PCR was per-
formed using 100 ng total RNA and the Power SYBR Green RNA-to-
Ct 1 step kit (Invitrogen) in an ABI 7500FAST PCR thermocycler
(Applied Biosystems). Three to four replicates were performed for
each RNA sample, and three independent RNA samples were
assayed for each genotype. Exonic primers that spanned introns
in tbx-2 (PO1048 [TCAAAACGAGAAGGTGACGG]; PO1072 [ATGTGT
GGGTAGTGAAGCGG]) and ama-1 (PO1061 [AGGCGAAGGATGTGTT
GTG]; PO1062 [TCACCGTGTTCTTTGGGTC]) were used, and the
level of tbx-2 expression relative to that of ama-1 was compared
in N2 and nfya-1(ok1174) animals using the 2ΔΔCt method (Livak
and Schmittgen, 2001).
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cu13 arose spontaneously in the tbx-2(bx59) background and
was outcrossed with wild-type N2. Self-progeny of cu13/+; tbx-2
(bx59)/+ heterozygotes were recovered at 16 1C. Five percent of
these isolated strains exhibited highly penetrant L1 arrest when
shifted to 25 1C (n¼119). Animals homozygous for unlinked alleles
are expected to arise at a frequency of 6.25%, indicating cu13 is an
unlinked, recessive enhancer of tbx-2(bx59). SNP mapping using
the polymorphic strain CB4856 indicated cu13 maps on LGII left of
pkP2103 (LGII bp 3828,608) (Davis et al., 2005). To outcross cu13
from the tbx-2(bx59) background, progeny of cu13++/+ dpy-10
(e128) unc-4(e120); tbx-2(bx59)/+ animals were picked to indivi-
dual plates and screened for animals that lacked the tbx-2(bx59)
allele by PCR and that segregated 100% non-Dpy non-Unc progeny.
This strain OK0814 was veriﬁed to be homozygous for cu13 by
crossing back into tbx-2(bx59) and recovering animals exhibiting
the enhanced L1 arrest phenotype.
Illumina paired-end sequencing was used to sequence genomic
DNA from OK0660 [tbx-2(bx59)], OK0661 [cu13; tbx-2(bx59)],
OK0814 [cu13], and N2, and we obtained 59- to 79-fold coverage
for each genome. Sequences were aligned to the reference C. elegans
genome (WS220; www.wormbase.org) using Bowtie 2 (Langmead
and Salzberg, 2012), and SNP/INDEL variants were identiﬁed using
the SAMtools package (Li et al., 2009). Variants were annotated
with ANNOVAR software (Wang et al., 2010) using genome anno-
tatons retrieved from the USCS Genome Broswer (ce10/WS220).
Variants were compared between genomes using Microsoft Access,
and variants and the underlying sequence reads were visualized
using the Integrative Genomics Viewer (IGV) (Thorvaldsdottir et al.,
2012). No SNP/INDELs affecting coding sequences on LGII speciﬁ-
cally in the OK0661 and OK0814 genomes were found. To identify
deletions, base calls for LGII output from Bowtie 2 SAM ﬁles were
directly entered into a Microsoft Access database, and regions of
low sequence coverage in the OK0661 and OK0814 were manually
examined using the IGV. cu13 is a 5116 bp deletion/1 bp insertion
(A/T) that removes bp 460,880–465,995 of LGII (WS220).
Microscopy
Worms were visualized using Zeiss Axioskop and AxioImager
microscopes equipped for DIC and ﬂuorescence microscopy, and
images were captured using an Axiocam MRm camera and
AxioVision or Zen 2011 software.Fig. 1. Wild type Ptbx-2::gfp expression. (A) Schematic diagram of Ptbx-2::gfp. Blue
dots indicate proximal (203 bp) and distal (3566 bp) CCAAT-boxes. (B) and
(C) Fluorescence and DIC images of Ptbx-2::gfp expression in the pharynx of a
1.5 fold stage embryo (anterior is left). (D)–(G) Fluorescence and DIC images of the
head (D) and (E) and lateral surface (F) and (G) of young adult animals expressing
Ptbx-2::gfp. Four GFP expressing neurons outside the pharynx are visible in
D (arrowheads), and a region of in focus gut autoﬂuorescence is visible in F
(arrow). The width of the seam cells, which do not express GFP in wild-type
animals, is indicated by brackets in G.Results
nfyc-1 negatively regulates Ptbx-2::gfp expression
tbx-2 is expressed in a dynamic pattern throughout the
C. elegans life cycle, and we are interested in identifying mechan-
isms that regulate tbx-2 expression. We have previously described
a tbx-2::gfp promoter fusion that contains approximately 3.7 kb of
tbx-2 5′-ﬂanking DNA fused to the gfp coding sequence just
downstream of the tbx-2 translational initiation site, and we
subsequently refer to it as Ptbx-2::gfp (Fig. 1A) (Roy Chowdhuri
et al., 2006). In embryos, Ptbx-2::gfp was expressed in pharyngeal
precursors beginning at the 100–200 cell stage, and GFP remained
detectable in the pharynx until near hatching (Fig. 1B and C). During
larval and adult stages Ptbx-2::gfp was strongly expressed in several
neurons in the head and occasionally neurons in the tail, but it was not
expressed in the pharynx or other tissues (Fig. 1D–G).
To identify mechanisms regulating tbx-2 expression, we used
feeding RNAi to knock down expression of transcription factor genes
in strains containing a chromosomally integrated Ptbx-2::gfpreporter and screened for changes in GFP expression (see Materials
and Methods). We examined 725 of the 934 predicted transcription
factor genes in the C. elegans genome (Supplemental Table 1)
(Reinke et al., 2013) and found that RNAi knock down of two
genes, nfyc-1 and tbx-2 itself, resulted in ectopic Ptbx-2::gfp expres-
sion in the gut. By comparison, no genes were identiﬁed whose
knockdown eliminated Ptbx-2::gfp expression. In the remainder
Fig. 2. Ectopic Ptbx-2::gfp expression in animals with reduced NF-Y. Fluorescence (left) and DIC (right) images of L4 or young adult animals of the indicated genotypes
ectopically expressing Ptbx-2::gfp in seam cells and gut. GFP accumulates in cell nuclei and cytoplasm. Seam cells are arranged in longitudinal rows on the lateral surface of
the worm, and GFP expressing seam cells are marked with arrowheads. The gut is a epithelial tube extending through the central body, and representative GFP containing
gut cell nuclei are marked with arrows. For RNAi experiments, (C), (E), and (F) are in an rrf-3(+) background, while (A), (B) and (D) are in an RNAi hypersensitive rrf-3(pk1426)
background. In all cases, ectopic Ptbx-2::gfp expression patterns were indistinguishable in wild-type and rrf-3 mutant backgrounds.
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related genes in tbx-2 regulation.
To more closely examine the effect of nfyc-1 knockdown, we
examined Ptbx-2::gfp expression in nyfc-1(RNAi) animals produced
by injecting double-stranded nfyc-1 RNA (Fire et al., 1998). These
nfyc-1(RNAi) animals exhibited ectopic GFP expression throughout
the gut, as observed in the feeding RNAi screen, as well as in the
seam cells, a group of hypodermal blast cells arranged as long-
itudinal rows on the lateral surface of the worm (Fig. 2A and B).
In both tissues, ectopic Ptbx-2::gfp expression was limited to L4
and adult animals. These results suggest NFYC-1 represses tbx-2
promoter activity in seam and gut cells.
The NF-Y complex negatively regulates tbx-2 expression
nfyc-1 encodes the C-subunit of the conserved heterotrimeric tran-
scription factor NF-Y. In mammals, NF-Y is a ubiquitously expressedcomplex comprised of A, B, and C subunits (Mantovani, 1999). In
C. elegans, there are two distinct NF-Y complexes that share B and C
subunits encoded by the nfyb-1 and nfyc-1 genes, respectively, but
they contain different A subunits encoded by either nfya-1 or nfya-2
(Deng et al., 2007). To ask if either NF-Y complex represses tbx-2
expression, we examined Ptbx-2::gfp in animals in which other NF-Y
subunits were individually knocked down by RNAi. As in nfyc-1(RNAi)
animals, Ptbx-2::gfpwas ectopically expressed in seam cells and gut of
nfya-1(RNAi) and nfyb-1(RNAi) animals in late larval stages through
adulthood (Fig. 2C–F). In contrast, nfya-2(RNAi) animals exhibited only
infrequent and faint expression in seam cells of the head, suggesting
NFYA-2 plays only a minor role in repressing Ptbx-2::gfp expression
(Fig. 3). As a control to ask if NF-Y knockdown speciﬁcally derepressed
Ptbx-2::gfp, we examined expression of two additional pharyngeal
markers ceh-22::gfp and a myo-2 enhancer::gfp and found their
expression was unaffected by nfyb-1(RNAi) (Okkema and Fire, 1994;
Okkema et al., 1997) (data not shown). Together these results indicate
Fig. 3. Weak ectopic Ptbx-2::gfp expression in nfya-2(RNAi). Fluorescence (left) and DIC (right) images of a young adult animal ectopically expressing Ptbx-2::gfp in the seam
cells of the head. Arrows indicate faint ectopic Ptbx-2::gfp expression in seam cells, and an arrowhead indicates wild-type expression of Ptbx-2::gfp in a neuron. This animal is
in an rrf-3(+) background.
Fig. 4. nfya-1(ok1174) and nfyb-1(cu13) mutations. (A) Schematic diagram of the nfya-1 gene numbered according to accession NC_003284. Dark gray boxes indicate nfya-1
exons and the direction of transcription. nfya-1(ok1174) is an 1837 bp deletion/2 bp insertion (bracket; bp 11,944,734–11,946,570) that removes most of the nfya-1 coding
sequence and introduces a frame-shift. (B) Schematic diagram of the NFYA-1 protein (accession NP_509999) indicating the HAP2 similarity domain (light gray box), which is
necessary for complex formation and DNA-binding (Mantovani et al., 1994). The NFYA-1 protein is predicted to be truncated upstream of the HAP2 domain after residue 55 in
this mutant (gray circle). (C) Schematic diagram of the nfyb-1 genomic region numbered according to accession AF025470. Dark gray boxes indicate nfyb-1 exons and the
direction of transcription. nfyb-1(cu13) is a 5116 bp deletion/1 bp insertion (bracket; bp 12,583–17,698) removing 5 exons and a portion of the 3′ UTR region. (D) Schematic
diagram of the NFYB-1 protein (accession CCD65581) indicating the histone-fold domain (HFD) necessary for DNA binding (light gray box). The NFYB-1 protein is predicted
to be truncated downstream of the HFD after residue 189 in this mutant (gray circle).
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expression.
To further assess the speciﬁcity of the loss of NF-Y phenotype,
we examined Ptbx-2::gfp expression in an nfya-1 null mutant
(Fig. 4A and B). nfya-1(ok1174) homozygotes were viable but
exhibited slow growth and male mating defects consistent with
the phenotypes in previously described nfya-1 mutants (Deng
et al., 2007). Just as when NF-Y components were knocked down
by RNAi, nfya-1(ok1174) mutants ectopically expressed Ptbx-2::gfp
in seam cells and the gut (Fig. 2G and H; Table 1). However, unlike
our RNAi experiments, ectopic Ptbx-2::gfp expression in the gut of
nfya-1(ok1174) mutants was detectable as early as the L1 stage
(Fig. 5A and B). These results suggest that NF-Y regulation of tbx-2
expression occurs throughout larval development, and that nfya-1
(RNAi) is less effective in knocking out activity of the NF-Y complex
than the null mutant.Two CCAAT-boxes in the tbx-2 promoter are important
for tbx-2 regulation
NF-Y binds CCAAT-boxes, which are common eukaryotic reg-
ulatory sites typically found in promoters approximately 60 to
100 bp upstream of the transcriptional start site (Mantovani,
1999). While the transcriptional start site for tbx-2 is not known,
the tbx-2 promoter contains two CCAAT-boxes located at 3566 bp
and 203 bp upstream of the translational start codon, and we refer
to these as the distal and proximal sites, respectively (Fig. 1A).
To ask if these sites regulate tbx-2 promoter activity, we examined
the effect of mutating them on Ptbx-2::gfp expression in multiple
independent transgenic lines. A mutation of the proximal CCAAT-
box (Ptbx-2prox::gfp) resulted in very frequent ectopic GFP expres-
sion in seam cells and gut (Fig. 6; Table 1). In comparison, a
mutation of the distal CCAAT-box (Ptbx-2dist::gfp) resulted in much
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Ptbx-2dist::gfp was expressed more frequently in seam cells and
more widely throughout the gut than wild-type Ptbx-2::gfp, for which
the occasional gut expression we observed was limited to posterior
cells. A double mutant of both CCAAT-boxes (Ptbx-2prox+dist::gfp)
was expressed similarly to the Ptbx-2prox::gfp single mutant in seam
cells, but it was expressed less frequently in the gut than Ptbx-2prox::gfpFig. 5. Ectopic Ptbx-2::gfp is expressed in early larvae in nfya-1(ok1174) and nfyb-1(cu13)
nfyb-1(cu13) L1 larvae expressing Ptbx-2::gfp. Neuronal expression Ptbx-2::gfp is marked
arrows.
Table 1
Frequency of Ptbx-2::gfp expression is seam cells and gut.
Genotype % Animals expressing
Ptbx-2::gfp in seam
cells
% Animals
expressing
Ptbx-2::gfp in gut
n
cuIs23[Ptbx2::gfp] 0 6 148
cuIs23; nfya-1(ok1174) 46 100 70
cuEx683[Ptbx-2prox::gfp]a 93 86 105
cuEx684[Ptbx-2prox::gfp]a 71 52 85
cuEx680[Ptbx-2dist::gfp]a 9 8 65
cuEx672[Ptbx-2prox+dist::
gfp] b
79 38 29
cuIs23; nfyb-1(cu13) 95 100 81
a Expression was scored in L3 to young adult hermaphrodites.
b Expression was scored in L2 to young adult hermaphrodites.(Table 1). We conclude that the proximal CCAAT-box is the major site
repressing Ptbx-2::gfp in the seam cells and gut. The distal site also
plays a minor role in repressing Ptbx-2::gfp, but it may have an
additional activating role, because the double CCAAT-box mutant had
less frequent expression than the proximal mutant alone. Because
both loss of NF-Y function and these CCAAT-box mutations lead to
ectopic Ptbx-2::gfp expression in identical patterns, it is likely that NF-Y
directly represses the tbx-2 promoter.
NF-Y represses endogenous tbx-2 expression
While NF-Y clearly represses Ptbx-2::gfp, we wanted to know if
it regulates expression of the endogenous tbx-2 gene. tbx-2 mRNA
levels in wild-type and nfya-1(ok1174) mutants were compared
using quantitative real-time PCR. Because nfya-1(ok1174) larvae
grow more slowly than wild type, we used total RNA isolated from
synchronized L1 animals to avoid differences in mutant and wild-
type populations resulting from these different larval growth rates.
Ectopic Ptbx-2::gfp expression was ﬁrst detectable in the guts of
nfya-1(ok1174) L1s (Fig. 5B), and we hypothesized that ectopic
expression of endogenous tbx-2 expression would similarly begin
at this stage. We found nfya-1(ok1174) mutants over-expressed
tbx-2 1.4070.07 fold relative to wild-type. While this difference is
relatively small, it is highly signiﬁcant (p¼0.005), and it likely
reﬂects the onset of ectopic tbx-2 expression. These results argue. Fluorescence (left) and DIC (right) images of wild-type (A), nfya-1(ok1174) (B), and
with arrowheads. Ectopic expression in representative gut nuclei is marked with
Fig. 6. Ectopic Ptbx-2::gfp expression in CCAAT-box mutants. Fluorescence (left) and DIC (right) images of L4 or young adult animals expressing Ptbx-2::gfp reporters in
which the distal or proximal CCAAT-boxes were mutated to AACCT. Ptbx-2prox::gfp and Ptbx-2dist::gfp are expressed in the seam cells (A) and gut (B) as described in the text.
Table 2
Viability of tbx-2(bx59) and nfyb-1(cu13) mutants.
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Ptbx-2::gfp.Genotype a % Dead embryos % Arrested L1s % L4/adult n
+/+ 2 0 98 60
tbx-2(bx59) 6 44 50 64
nfyb-1(cu13) 4 0 95 22
nfyb-1(cu13); tbx-2(bx59) 2 98 0 47
a Phenotypes were scored in the progeny of L4 hermaphrodites shifted to 25 1C.
Animals reaching L4 and adult stages were scored after 3 days.
Table 3
Effect of nfyb-1(RNAi) on tbx-2(bx59) and nfyb-1(cu13); tbx-2(bx59) mutants.
Genotype a % L4/Adult n
+/+ 84 400
tbx-2(bx59) 46 483
nfyb-1(cu13); tbx-2(bx59)b 0 422
nfyb-1(RNAi)b 92 350
nfyb-1(RNAi); tbx-2(bx59)b 11 385
nfyb-1(RNAi); nfyb-1(cu13); tbx-2(bx59)b 0 135
a Phenotypes were scored in the progeny of L4 hermaphrodites shifted to 25 1C.
Animals reaching L4 and adult stages were scored after 3 days.
b Pooled data from embryos collected 12–16 and 24–27 h post-injection.
No differences were observed at these different time points.An nfyb-1 mutation enhances the phenotype of a tbx-2 mutant
tbx-2(bx59) is a temperature sensitive mutant exhibiting par-
tially penetrant lethality and pharyngeal defects, and it provides a
compromised genetic background that can be used to identify
genes affecting tbx-2 activity (Huber et al., 2013). We isolated a
spontaneous mutation called cu13 that enhances tbx-2(bx59)
lethality and, using SNP mapping and whole genome sequencing,
we identiﬁed cu13 as an allele of nfyb-1 (Fig. 4C) (Davis et al.,
2005; Sarin et al., 2008). nfyb-1(cu13) is a 5116 bp deletion/1 bp
insertion that removes the last 5 exons of this gene. Over 50% of
the nfyb-1 coding sequence is deleted, and this deletion is
predicted to truncate the NFYB-1 protein downstream of the
histone fold domain (HFD) involved in DNA binding (Fig. 4D).
The endpoints of the cu13 deletion are located within tandem
repeat sequences that are enriched in this region (Wormbase
WS230), and these repeats likely contributed to formation of this
deletion.
We out-crossed nfyb-1(cu13) from the tbx-2(bx59) mutant
background and found that these nfyb-1(cu13) single mutants
ectopically expressed Ptbx-2::gfp in a pattern identical to nfya-1
(ok1174) mutants. Nearly all nfyb-1(cu13) animals expressed Ptbx-
2::gfp in seam cells and gut at the L4 and adult stages (Fig. 2I and J;
Table 1). As in nfya-1 mutants, ectopic Ptbx-2::gfp expression
was detectable in the gut as early L1 stage (Fig. 5C), and it
increased in strength and frequency the seam cells through larval
development.
This unexpected ﬁnding of an nfyb-1 mutation as an enhancer
of the tbx-2 mutant phenotype indicates NF-Y regulation is crucial
for tbx-2 expression in vivo, and we compared the phenotype of
nfyb-1(cu13); tbx-2(bx59) double mutants with those of tbx-2
(bx59) and nfyb-1(cu13) single mutants. When tbx-2(bx59) her-
maphrodites were shifted to the non-permissive temperature,
their progeny exhibited a partially penetrant L1 arrest phenotype
(Huber et al., 2013), and this phenotype was strongly enhanced by
nfyb-1(cu13). Forty-four percent of tbx-2(bx59) animals arrested as
L1 larvae, and most of the remaining animals grew to adulthood
(Table 2; Table 3). In comparison, all nfyb-1(cu13); tbx-2(bx59)
double mutants arrested as L1 animals, and none of these animals
grew to adults. As with other NF-Y mutants (Deng et al., 2007), no
L1 arrest was observed in nfyb-1(cu13) single mutants, indicatingthe lethality in the double mutants results from enhancement of
the tbx-2(bx59) phenotype.
tbx-2(bx59) single mutants exhibit variable pharyngeal defects
(Huber et al., 2013). Nineteen percent of these animals have a
severe phenotype with a clear loss of ABa-derived pharynx, similar
to that observed in tbx-2 null mutants (Roy Chowdhuri et al.,
2006). The remaining animals exhibit either moderate morpholo-
gical defects (56%) or normal pharyngeal morphology (25%)
(Huber et al., 2013). We expected that the enhanced L1 arrest
observed in nfyb-1(cu13); tbx-2(bx59) double mutants would
result from increased severity of the pharyngeal defect. However,
we did not ﬁnd any nfyb-1(cu13); tbx-2(bx59) animals exhibiting
the severe phenotype and a loss of ABa-derived pharynx. Rather
nfyb-1(cu13); tbx-2(bx59) animals exhibited a moderate morpho-
logical defect in the pharynx (81%, n¼28) at a frequency higher
than tbx-2(bx59) single mutants (54%, n¼26) (Fig. 7). The fact that
these pharyngeal defects were not enhanced indicates nfyb-1
(cu13); tbx-2(bx59) lethality did not result from eliminating tbx-2
expression in the pharynx.
Fig. 7. Pharyngeal morphology is similar in tbx-2(bx59) and nfyb-1(cu13); tbx-2
(bx59). DIC micrographs of the pharynxes of L1 animals: (A) wild type; (B) a
moderately affected tbx-2(bx59) animal; (C) an nfyb-1(cu13); tbx-2(bx59) double
mutant. The procorpus (arrowhead) and the metacorpus (arrow) consisting
primarily of ABa-derived pharyngeal muscles are marked. These regions are
present but morphologically abnormal in tbx-2(bx59) and nfyb-1(cu13); tbx-2
(bx59) mutants.
Table 4
Effect of tbx-2(RNAi) on nfyb-1(cu13) and nfyb-1(cu13); tbx-2(bx59) mutants.
Genotypea %L4/Adult n
+/+ 82 453
nfyb-1(cu13) 90 451
nfyb-1(cu13); tbx-2(bx59) 0 315
tbx-2(RNAi)b 31 452
tbx-2(RNAi); nfyb-1(cu13)b 7 343
tbx-2(RNAi); nfyb-1(cu13); tbx-2(bx59)b 0 289
a Phenotypes were scored in the progeny of L4 hermaphrodites shifted to 25 1C.
Animals reaching L4 and adult stages were scored after 3 days.
b Pooled data from embryos collected 12–16 and 24–27 h post-injection.
No differences were observed at these different time points.
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The synergistic phenotypes observed in nfyb-1(cu13); tbx-2
(bx59) double mutants argue that both of these genes function
in the same pathway in vivo [see (Herman and Yochem, 2005)].
However, we do not know whether these individual mutations
result in gain- or loss-of-function. The region deleted in nfyb-1
(cu13) encodes no recognizable functional domains, and this allele
could produce a deleted protein that retains the HFD (Fig. 4D).
tbx-2(bx59) is a missense mutation that substitutes a conserved
histidine residue in the dimerization domain of the TBX-2 DNA-
binding domain with tyrosine (H154Y; accession CC69847)
(K. Chow, personal communication) (Huber et al., 2013), and
mutations affecting nearby residues in the dimerization domain
of human TBX1 are gain-of-function mutations that underlie some
cases of DiGeorge and velocardiofacial syndromes (Zweier et al.,
2007). To examine the nature of nfyb-1(cu13) and tbx-2(bx59)
mutations we used RNAi to knock down activity of nfyb-1 or tbx-2
in either tbx-2(bx59) or nfyb-1(cu13) mutants, respectively, and in
the nfyb-1(cu13); tbx-2(bx59) double mutant.
We predicted that if nfyb-1(cu13) was a loss-of-function allele,
nfyb-1(RNAi) should increase lethality in tbx-2(bx59) mutants,
whereas, if it was a gain-of-function allele, nfyb-1(RNAi) should
suppress larval lethality in nfyb-1(cu13); tbx-2(bx59) double
mutants. We observed a strongly enhanced larval lethal phenotype
in nfyb-1(RNAi); tbx-2(bx59) double mutants compared to tbx-2
(bx59) or nfyb-1(RNAi) alone, and we saw no suppression of the
larval lethal phenotype in nfyb-1(RNAi); nfyb-1(cu13); tbx-2(bx59)
animals (Table 3). Thus we conclude that nfyb-1(cu13) is a loss-of-
function allele, and that loss of nfyb-1 enhances the tbx-2(bx59)
phenotype.
We similarly predicted that if tbx-2(bx59) was a loss-of-
function allele, tbx-2(RNAi) would enhance the lethality of nfyb-1
(cu13) mutants, while, if it was a gain-of-function allele, tbx-2(RNAi) would suppress lethality of nfyb-1(cu13); tbx-2(bx59) dou-
ble mutants. Again we found that tbx-2(RNAi) strongly enhanced
the larval lethality in the nfyb-1(cu13) background, while we saw
no suppression of lethality in tbx-2(RNAi); nfyb-1(cu13); tbx-2
(bx59) animals (Table 4). We also asked whether one functional
allele of tbx-2was sufﬁcient for viability when nfyb-1 was reduced.
To investigate this, we tested if nfyb-1(RNAi) would enhance
lethality in animals heterozygous for the tbx-2(ok529) null mutant.
tbx-2(ok529) results in recessive L1 lethality, but tbx-2(ok529)/+
heterozygotes were completely viable (Roy Chowdhuri et al.,
2006). We examined the progeny of tbx-2(ok529)/+ hermaphro-
dites that had been injected with nfyb-1 dsRNA, but we did not see
a difference in the number of viable, heterozygous tbx-2(ok529)/+
progeny segregating from animals either injected or non-injected
control animals (n¼412 and 401, respectively). Together these
results indicate that tbx-2(bx59) is a hypomorphic, loss-of-function
allele, and they suggest that, at the non-permissive temperature,
tbx-2(bx59) mutants have less TBX-2 activity than tbx-2(ok529)/+
heterozygotes.Discussion
Here we show that NF-Y is a tissue- and stage-speciﬁc repressor
of C. elegans tbx-2 gene expression. Loss of NF-Y leads to ectopic
expression of Ptbx-2::gfp in the seam cells and gut of larvae and
adults and increased expression of endogenous tbx-2. NF-Y repres-
sion of tbx-2 is likely to be direct, as both loss of NF-Y and
mutation of CCAAT-boxes within the tbx-2 promoter lead to nearly
identical patterns of ectopic Ptbx-2::gfp expression. Finally the fact
that an nfyb-1 mutation enhances the lethal phenotype of a
hypomorphic tbx-2 mutant argues that NF-Y repression is crucial
for normal tbx-2 function in vivo.
C. elegans NF-Y represses transcription
CCAAT-boxes are common eukaryotic regulatory sequences,
found near the transcription start site in approximately 12% of
human promoters (Dolﬁni et al., 2009). The conserved NF-Y
complex is the major CCAAT-box binding factor and NF-Y binding
is typically associated with transcriptional activation (Mantovani,
1999). However, examples of transcriptional repression are also
known (Buschlen et al., 2003; Ceribelli et al., 2008). Genome wide
characterization of NF-Y targets has not been carried out in
invertebrate model organisms. However, characterization of the
Drosophila p53 and sevenless genes indicates that NF-Y can
function as an activator in this organism (Tue et al., 2011;
Yoshioka et al., 2012).
C. elegans NF-Y has only begun to be characterized, but, in the
few known examples, it functions as a transcriptional repressor.
As we have found for tbx-2, expression of the Hox genes egl-5 and
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tissue-speciﬁc, and loss of nfya-1 or mutation of a CCAAT-box in
the egl-5 promoter leads to ectopic egl-5::gfp expression in seam
cells and elsewhere in the hypodermis. This incomplete overlap
with the tissues where Ptbx-2::gfp is repressed suggests the
speciﬁc mechanisms by which NF-Y represses tbx-2 and egl-5 are
distinct. Indeed, NF-Y interacts with the MES-2/MES-6 PcG com-
plex to repress egl-5, but we have not observed a role for MES-2/
MES-6 in repressing tbx-2 expression.
At this point, it is not known what other genes NF-Y regulates
in C. elegans, or whether C. elegans NF-Y can activate as well as
repress transcription. Indeed, our work suggests the distal CCAAT-
box in Ptbx-2::gfp weakly activates expression, implying NF-Y can
both repress and activate transcription. While C. elegans NF-Y
subunits are conserved with those in mammals, they do have
some interesting differences that might affect their activities. For
example, C. elegans NFYC-1 lacks a glutamine-rich transcriptional
activation domain found in mammalian NF-YC subunits (Coustry
et al., 1996; Deng et al., 2007). This difference suggests that
C. elegans NF-Y may not be as strong an activator as mammalian
NF-Y, or that it activates transcription with co-activators, as has
been observed with the yeast HAP complex (Olesen and Guarente,
1990). In another example, C. elegans NFYA-1 contains a G to D
substitution converting the highly conserved GXGGRF motif to
GXDGRF. In human NF-Y, this affected G directly contacts the a
base in the CCAAT box (Nardini et al., 2013), and the G to D
substitution could affect NF-Y binding afﬁnity or speciﬁcity. Inter-
estingly NFYA-2 contains an XGGRF more similar to the motif in
human NF-YA, and these differences suggest the NF-Y complexes
containing NFYA-1 or NFYA-2 may target different sites in the
genome. Additional work will be necessary to identify more
C. elegans NF-Y targets, and determine if NF-Y can activate
transcription in this organism.
Ptbx-2::gfp expression is speciﬁcally repressed in seam cells
and the gut
C. elegans NF-Y is broadly expressed, yet loss of NF-Y regulation
results in Ptbx-2::gfp expression only in the seam cells and gut.
This suggests that the tbx-2 promoter is poised for expression in
these tissues. Seam cells and gut are derived from different germ
layers and are lineally unrelated (Sulston et al., 1983). However,
these tissues share the common feature that they undergo DNA
replication each larval stage. Seam cells replicate DNA and divide
in a stem cell-like pattern near the end of each stage, producing
one differentiated daughter and one seam cell daughter (Joshi
et al., 2010), and gut cells replicate DNA and undergo either a
nuclear division or endoreduplication at each larval stage
(Hedgecock and White, 1985). Perhaps C. elegans tbx-2 is primed
for low level or transient expression in seam cells and gut to
promote DNA replication, but NF-Y represses expression to unde-
tectable levels under most circumstances.
Mammalian TBX2 and TBX3 are orthologs of C. elegans tbx-2,
and they function as regulators of cell cycle progression and as
inhibitors of cellular senescence [reviewed in (Lu et al., 2010)].
Interestingly, they are both believed to be activated by NF-Y (Smith
et al., 2011; Teng et al., 2008). Although this regulation is different
fromwhat we have observed for C. elegans tbx-2, it shows NF-Y is a
regulator of T-box gene expression in very different species.
NF-Y affects tbx-2 activity in vivo
Our ﬁnding that the spontaneous mutant nfyb-1(cu13)
enhances lethality of tbx-2(bx59) demonstrates NF-Y plays an
important role in regulating tbx-2 activity in vivo. However the
mechanism by which loss of NF-Y regulation enhances tbx-2(bx59)lethality is unclear. Because nfyb-1(cu13) is viable in a tbx-2(+)
background, simple loss of repression resulting in expression of
tbx-2 in seam cells and gut would not explain the enhanced
lethality in nfyb-1(cu13); tbx-2(bx59) double mutants. One possi-
bility is that NF-Y and TBX-2 have partially overlapping functions
regulating other downstream genes, and loss of both TBX-2 and
NF-Y regulation leads to lethality in nfyb-1(cu13); tbx-2(bx59)
mutants. Alternatively, mutations in nfyb-1 and tbx-2 may lead
to even higher levels of tbx-2 overexpression than nfyb-1 mutants
alone. We identiﬁed tbx-2 in our RNAi screen as a potential
negative regulator of Ptbx-2::gfp, and we are currently investigat-
ing whether NF-Y and TBX-2 function in parallel to repress the tbx-
2 promoter.
Like our observations with nfyb-1, other genetic modiﬁers of
T-box gene mutants reveal important mechanisms regulating
T-box gene expression and activity. C. elegans TBX-2 is post-
translationally modiﬁed by SUMOylation, and we have shown that
reducing SUMOylation enhances the tbx-2(bx59) phenotype
(Huber et al., 2013). Likewise reducing the mouse MOZ histone
acetyltransferase enhances defects resulting from haploinsufﬁ-
ciency of Tbx1, and it is suggested that the epigenetic regulatory
state of human TBX1 contributes to the variable severity of
symptoms observed in DiGeorge syndrome patients (Voss et al.,
2012). Characterization of additional modiﬁers of T-box gene
mutations will likely continue to provide novel insights into T-
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